Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein S
- 1 January 1989
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 30 (1), 14-21
- https://doi.org/10.1002/ajh.2830300104
Abstract
The profile of blood coagulation and fibrinolysis was studied in detail in eight patients with acute thrombotic thrombocytopenic purpura (TTP). In the majority of the patients, fibrinogen, factor XIII, antithrombin III, α2-plasmin inhibitor, plasminogen, and α2-macroglobulin were normal, whereas FDP, plasmin-α2-plasmin inhibitor complex, and tissuetype plasminogen activator antigen were marginally or moderately elevated. Low fibronectin values were observed in four patients. Protein C and C4b-binding protein were nearly normal, whereas total protein S and free protein S were reduced in five and six patients, respectively. A positive correlation was found between total protein S and C4 and between free protein S and C3. von Willebrand factor antigen (vWf:Ag) and ristocetin cofactor (RCof) were either normal or elevated, but RCof/vWf:Ag ratio was decreased in seven patients. Crossed immunoelectrophoresis and sodium dodecyl sulfate (SDS)-agarose gel electrophoresis revealed that the large vWf multimers were either absent from or relatively decreased in all patients except one. In addition, one patient had unusually large vWf multimers, and a low-molecular-weight vWf fragment was apparently observed in three patients. These findings indicate that the intravascular generation of thrombin and plasmin was minimal in TTP and suggest that the alterations of the vWf molecule were caused not only by consumption through its participation in platelet thrombus formation but also by accelerated proteolysis. Low protein S values would be related to the immunological abnormalities underlying TTP.Keywords
This publication has 35 references indexed in Scilit:
- Plasmin-α2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulationAmerican Journal of Hematology, 1988
- Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.Journal of Clinical Investigation, 1986
- Excessive fibrinolysis in suspected amyloidosis: Demonstration of plasmin‐α2‐plasmin inhibitor complex and von Willebrand factor fragment in plasmaAmerican Journal of Hematology, 1986
- Case Report: Von Willebrand Factor Abnormalities and Endothelial Cell Perturbation in a Patient with Acute Thrombotic Thrombocytopenic PurpuraThe American Journal of the Medical Sciences, 1986
- Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.Journal of Clinical Investigation, 1985
- Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.Journal of Clinical Investigation, 1984
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982
- Alterations of Factor VIII von Willebrand Factor in Clinical Conditions Associated with an Increase in its Plasma ConcentrationBritish Journal of Haematology, 1981
- Thrombotic Thrombocytopenic Purpura: Analysis of 48 Unselected CasesSeminars in Thrombosis and Hemostasis, 1980
- Determination of α2-macroglobulin as trypsin-protein esteraseClinica Chimica Acta; International Journal of Clinical Chemistry, 1966